Researchers Identify Rack::Static Vulnerability Enabling Data Breaches in Ruby Servers - The Hacker News
16 hours ago • Google News
Rubius Therapeutics Inc (RUBY)
US$ 1.12-13.18%
Price Chart
Key Statistics
Market Cap
$ 5.16M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
21.01M
52W High
$ 0.17
52W Low
$ 0.17
Dividend Yield
0.00%
Beta
2.21
Technicals
50-Day MA
0.0217
200-Day MA
0.0199
52 Week High
0.175
52 Week Low
0.175
About RUBY
Rubius Therapeutics, Inc., a biopharmaceutical company, focuses on the development of red cell therapeutics for the treatment of cancer and autoimmune diseases.
Employees
6
Headquarters
Cambridge, MA
CEO
Ms. Dannielle Appelhans
Latest News
Obituary information for Ruby "Carolyn" Wallace Welchel - Henderson & Sons Funeral Home
3 days ago • Google News
Ruby Garrett Obituary (1923 - 2025) - Bellmead, TX - Waco Tribune-Herald - Legacy.com
6 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg